319 related articles for article (PubMed ID: 18634444)
1. [The pathophysiology underlying overactive bladder syndrome possibly due to benign prostatic hyperplasia].
Akino H; Maegawa M; Nagase K; Tanaka I; Nakai M; Ishida Y; Oyama N; Miwa Y; Yokoyama O
Hinyokika Kiyo; 2008 Jun; 54(6):449-52. PubMed ID: 18634444
[TBL] [Abstract][Full Text] [Related]
2. Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment.
Liu HT; Kuo HC
Urology; 2008 Jul; 72(1):104-8; discussion 108. PubMed ID: 18400272
[TBL] [Abstract][Full Text] [Related]
3. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia.
Oelke M; Baard J; Wijkstra H; de la Rosette JJ; Jonas U; Höfner K
Eur Urol; 2008 Aug; 54(2):419-26. PubMed ID: 18325657
[TBL] [Abstract][Full Text] [Related]
4. The profiles and patterns of detrusor overactivity and their association with overactive bladder symptoms in men with benign prostatic enlargement associated with detrusor overactivity.
Shahab N; Seki N; Takahashi R; Kajioka S; Takei M; Yamaguchi A; Naito S
Neurourol Urodyn; 2009; 28(8):953-8. PubMed ID: 19260093
[TBL] [Abstract][Full Text] [Related]
5. Comparisons of urodynamic findings and voiding habits in patients with concomitant benign prostatic hyperplasia and detrusor overactivity presenting with or without the symptom of urgency.
Tong YC
Urol Int; 2007; 78(3):219-25. PubMed ID: 17406130
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the prognostic factors for overactive bladder symptoms following surgical treatment in patients with benign prostatic obstruction.
Seki N; Yuki K; Takei M; Yamaguchi A; Naito S
Neurourol Urodyn; 2009; 28(3):197-201. PubMed ID: 18973143
[TBL] [Abstract][Full Text] [Related]
7. [The urodynamic diagnosis of benign prostatic hyperplasia with coexisting overactive bladder].
Chen Y; DU GH; Chen Z; Cai D; Zhang Q; Yuan XY; Zeng XY; Yang WM; Ye ZQ
Zhonghua Wai Ke Za Zhi; 2010 Dec; 48(23):1767-70. PubMed ID: 21211379
[TBL] [Abstract][Full Text] [Related]
8. Survey of overactive bladder symptoms influencing bother before and after treatment with tamsulosin hydrochloride in Japanese patients with benign prostatic hyperplasia.
Tsujimura A; Takao T; Miyagawa Y; Okuda H; Yamamoto K; Fukuhara S; Nakayama J; Ueda T; Kiuchi H; Hirai T; Tsujimoto Y; Miura H; Kanno N; Higashino M; Nakamura Y; Nishimura K; Nonomura N
Urology; 2011 Nov; 78(5):1058-62. PubMed ID: 21908025
[TBL] [Abstract][Full Text] [Related]
9. Urethral Sensations are Related to the Development of Detrusor Overactivity.
Yokoyama O; Miwa Y; Oyama N; Aoki Y; Ito H; Tanase K; Ishida H; Matsuta Y; Kusukawa N; Yamauchi H; Takahara N; Watanabe N; Tsuchiyama K; Yokoi S; Akino H
Low Urin Tract Symptoms; 2011 Sep; 3(2):59-63. PubMed ID: 26676387
[TBL] [Abstract][Full Text] [Related]
10. Multiple factors related to detrusor overactivity in Chinese patients with benign prostate hyperplasia.
Liu N; Man LB; He F; Huang GL; Wang H; Li GZ; Wang JW; Lü YW
Chin Med J (Engl); 2012 Nov; 125(21):3778-81. PubMed ID: 23106872
[TBL] [Abstract][Full Text] [Related]
11. Occurrence of overactive bladder in patients with benign prostatic hyperplasia in the Czech Republic.
Hanuš T; Zámečník L; Doležal T; Karmazínová Z
Urol Int; 2011; 86(4):407-13. PubMed ID: 21454947
[TBL] [Abstract][Full Text] [Related]
12. Correlation between lower urinary tract symptoms and urethral function in benign prostatic hyperplasia.
Nakai H; Yamanishi T; Yasuda K; Kitahara S; Suzuki T
Neurourol Urodyn; 2004; 23(7):618-22. PubMed ID: 15382181
[TBL] [Abstract][Full Text] [Related]
13. Association of symptoms with urodynamic findings in men with overactive bladder syndrome.
Al-Zahrani AA; Gajewski JB
BJU Int; 2012 Dec; 110(11 Pt C):E891-5. PubMed ID: 22928556
[TBL] [Abstract][Full Text] [Related]
14. Is benign prostatic obstruction surgery indicated for improving overactive bladder symptoms in men with lower urinary tract symptoms?
Cornu JN; Grise P
Curr Opin Urol; 2016 Jan; 26(1):17-21. PubMed ID: 26574877
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of urodynamic analysis in patients with benign prostatic enlargement complicated with diabetes mellitus.
Zhang K; Xu Z; Zhang J; Wang H; Zhang D; Shi B
Urol Int; 2008; 81(2):149-52. PubMed ID: 18758211
[TBL] [Abstract][Full Text] [Related]
16. [Interrelation of hyperactivity of bladder and infravesical obstruction in patients with benign prostate hyperplasia].
Bablumyan A
Georgian Med News; 2010 Dec; (189):7-11. PubMed ID: 21252402
[TBL] [Abstract][Full Text] [Related]
17. Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder.
Yokoyama T; Kumon H; Nagai A
Neurourol Urodyn; 2008; 27(5):417-20. PubMed ID: 17924444
[TBL] [Abstract][Full Text] [Related]
18. Androgens and bladder outlet obstruction: a correlation with pressure-flow variables in a preliminary study.
Koritsiadis G; Stravodimos K; Mitropoulos D; Doumanis G; Fokitis I; Koritsiadis S; Constantinides C
BJU Int; 2008 Jun; 101(12):1542-6. PubMed ID: 18294304
[TBL] [Abstract][Full Text] [Related]
19. An alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate glutamate-receptor antagonist can inhibit premicturition contractions in rats with bladder outlet obstruction.
Kitta T; Kakizaki H; Tanaka H; Sano H; Furuno T; Mitsui T; Moriya K; Nonomura K
BJU Int; 2007 Jul; 100(1):181-6. PubMed ID: 17488306
[TBL] [Abstract][Full Text] [Related]
20. [Pathophysiology and treatment of the overactive bladder syndrome in an aged male patient with voiding difficulty: pharmacological treatment].
Akino H
Hinyokika Kiyo; 2005 Sep; 51(9):609-13. PubMed ID: 16229374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
